DEF 14AThe Ballot
4D Molecular Therapeutics, Inc. files DEF 14A
Filed Apr 6, 2021 · 5y ago · Accession 0001193125-21-107762
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Ticker
- FDMT
- CIK
- 1650648
- Form type
- DEF 14A
- Filing date
- Apr 6, 2021
- Report date
- May 17, 2021
- Document
- d155968ddef14a.htm
- Size
- 622 KB